Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1014 | 2902 | 31.1 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
450 | 3 | BLADDER CANCER//CYSTECTOMY//BLADDER NEOPLASMS | 25609 |
298 | 2 | BLADDER CANCER//CYSTECTOMY//BLADDER NEOPLASMS | 18621 |
1014 | 1 | BLADDER CANCER//CYSTECTOMY//BLADDER PRESERVATION | 2902 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BLADDER CANCER | authKW | 1059226 | 28% | 12% | 813 |
2 | CYSTECTOMY | authKW | 737335 | 11% | 22% | 312 |
3 | BLADDER PRESERVATION | authKW | 551290 | 2% | 92% | 57 |
4 | RADICAL CYSTECTOMY | authKW | 508482 | 6% | 27% | 180 |
5 | MUSCLE INVASIVE BLADDER CANCER | authKW | 319391 | 2% | 53% | 57 |
6 | UROTHELIAL CARCINOMA | authKW | 293699 | 7% | 15% | 192 |
7 | UROTHELIAL CANCER | authKW | 291478 | 3% | 27% | 101 |
8 | INVASIVE BLADDER CANCER | authKW | 252587 | 1% | 56% | 43 |
9 | TRANSITIONAL CELL CARCINOMA | authKW | 173635 | 5% | 11% | 145 |
10 | BLADDER NEOPLASMS | authKW | 145844 | 5% | 9% | 150 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 73157 | 46% | 1% | 1340 |
2 | Oncology | 28949 | 52% | 0% | 1495 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 1302 | 9% | 0% | 271 |
4 | Hematology | 1 | 1% | 0% | 32 |
5 | Medicine, General & Internal | 1 | 2% | 0% | 65 |
6 | Pharmacology & Pharmacy | 1 | 3% | 0% | 98 |
7 | Surgery | 0 | 3% | 0% | 79 |
8 | Pathology | -0 | 1% | 0% | 22 |
9 | Geriatrics & Gerontology | -1 | 0% | 0% | 6 |
10 | Health Care Sciences & Services | -1 | 0% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROL | 106636 | 36% | 1% | 1055 |
2 | CARITAS ST JOSEF MED | 44630 | 1% | 19% | 22 |
3 | CLIN PIO XI | 43833 | 0% | 83% | 5 |
4 | DIRECTORATE CLIN ONCOL | 42952 | 0% | 58% | 7 |
5 | GENITOURINARY ONCOL SERV | 40983 | 1% | 10% | 40 |
6 | LBI ACR VIENNA CTO | 33663 | 0% | 80% | 4 |
7 | ONCOL PHYS | 32052 | 0% | 38% | 8 |
8 | WTZE EV | 31561 | 0% | 100% | 3 |
9 | ACR ITR CEADDP | 23669 | 0% | 75% | 3 |
10 | BLADDER CANC SECT | 21041 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 43945 | 3% | 5% | 89 |
2 | CLINICAL GENITOURINARY CANCER | 36838 | 2% | 7% | 49 |
3 | EUROPEAN UROLOGY | 28915 | 5% | 2% | 141 |
4 | JOURNAL OF UROLOGY | 26008 | 9% | 1% | 263 |
5 | WORLD JOURNAL OF UROLOGY | 16018 | 2% | 2% | 68 |
6 | BJU INTERNATIONAL | 15822 | 4% | 1% | 111 |
7 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 9515 | 4% | 1% | 126 |
8 | UROLOGY | 9472 | 4% | 1% | 122 |
9 | BRITISH JOURNAL OF UROLOGY | 8477 | 2% | 1% | 70 |
10 | CANCER | 8304 | 5% | 1% | 149 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BLADDER CANCER | 1059226 | 28% | 12% | 813 | Search BLADDER+CANCER | Search BLADDER+CANCER |
2 | CYSTECTOMY | 737335 | 11% | 22% | 312 | Search CYSTECTOMY | Search CYSTECTOMY |
3 | BLADDER PRESERVATION | 551290 | 2% | 92% | 57 | Search BLADDER+PRESERVATION | Search BLADDER+PRESERVATION |
4 | RADICAL CYSTECTOMY | 508482 | 6% | 27% | 180 | Search RADICAL+CYSTECTOMY | Search RADICAL+CYSTECTOMY |
5 | MUSCLE INVASIVE BLADDER CANCER | 319391 | 2% | 53% | 57 | Search MUSCLE+INVASIVE+BLADDER+CANCER | Search MUSCLE+INVASIVE+BLADDER+CANCER |
6 | UROTHELIAL CARCINOMA | 293699 | 7% | 15% | 192 | Search UROTHELIAL+CARCINOMA | Search UROTHELIAL+CARCINOMA |
7 | UROTHELIAL CANCER | 291478 | 3% | 27% | 101 | Search UROTHELIAL+CANCER | Search UROTHELIAL+CANCER |
8 | INVASIVE BLADDER CANCER | 252587 | 1% | 56% | 43 | Search INVASIVE+BLADDER+CANCER | Search INVASIVE+BLADDER+CANCER |
9 | TRANSITIONAL CELL CARCINOMA | 173635 | 5% | 11% | 145 | Search TRANSITIONAL+CELL+CARCINOMA | Search TRANSITIONAL+CELL+CARCINOMA |
10 | BLADDER NEOPLASMS | 145844 | 5% | 9% | 150 | Search BLADDER+NEOPLASMS | Search BLADDER+NEOPLASMS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PLOUSSARD, G , DANESHMAND, S , EFSTATHIOU, JA , HERR, HW , JAMES, ND , RODEL, CM , SHARIAT, SF , SHIPLEY, WU , STERNBERG, CN , THALMANN, GN , ET AL (2014) CRITICAL ANALYSIS OF BLADDER SPARING WITH TRIMODAL THERAPY IN MUSCLE-INVASIVE BLADDER CANCER: A SYSTEMATIC REVIEW.EUROPEAN UROLOGY. VOL. 66. ISSUE 1. P. 120 -137 | 100 | 89% | 26 |
2 | STERNBERG, CN , DONAT, SM , BELLMUNT, J , MILLIKAN, RE , STADLER, W , DE MULDER, P , SHERIF, A , VON DER MAASE, H , TSUKAMOTO, T , SOLOWAY, MS , (2007) CHEMOTHERAPY FOR BLADDER CANCER: TREATMENT GUIDELINES FOR NEOADJUVANT CHEMOTHERAPY, BLADDER PRESERVATION, ADJUVANT CHEMOTHERAPY, AND METASTATIC CANCER.UROLOGY. VOL. 69. ISSUE . P. 62-79 | 108 | 97% | 91 |
3 | BELLEFQIH, S , KHALIL, J , MEZONRI, I , ELKACEMI, H , KEBDANI, T , HADADI, K , BENJAAFAR, N , (2014) CONCOMITANT CHEMORADIO THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: CURRENT KNOWLEDGE, CONTROVERSIES AND FUTURE DIRECTIONS.CANCER RADIOTHERAPIE. VOL. 18. ISSUE 8. P. 779 -789 | 98 | 92% | 1 |
4 | ROSE, TL , MILOWSKY, MI , (2016) IMPROVING SYSTEMIC CHEMOTHERAPY FOR BLADDER CANCER.CURRENT ONCOLOGY REPORTS. VOL. 18. ISSUE 5. P. - | 79 | 89% | 1 |
5 | CAFFO, O , VECCIA, A , FELLIN, G , RUSSO, L , MUSSARI, S , GALLIGIONI, E , (2013) TRIMODALITY TREATMENT IN THE CONSERVATIVE MANAGEMENT OF INFILTRATING BLADDER CANCER: A CRITICAL REVIEW OF THE LITERATURE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 86. ISSUE 2. P. 176 -190 | 76 | 90% | 7 |
6 | PEDROSA, JA , KOCH, MO , CHENG, L , (2013) TUMOR-ASSOCIATED EDEMA IN BRAIN CANCER PATIENTS: PATHOGENESIS AND MANAGEMENT.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 13. ISSUE 11. P. 1281-1295 | 88 | 79% | 0 |
7 | YAFI, FA , NORTH, S , KASSOUF, W , (2011) FIRST-AND SECOND-LINE THERAPY FOR METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER.CURRENT ONCOLOGY. VOL. 18. ISSUE 1. P. E25 -E34 | 72 | 91% | 26 |
8 | RAGGI, D , MICELI, R , SONPAVDE, G , GIANNATEMPO, P , MARIANI, L , GALSKY, MD , BELLMUNT, J , NECCHI, A , (2016) SECOND-LINE SINGLE-AGENT VERSUS DOUBLET CHEMOTHERAPY AS SALVAGE THERAPY FOR METASTATIC UROTHELIAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.ANNALS OF ONCOLOGY. VOL. 27. ISSUE 1. P. 49 -61 | 50 | 93% | 5 |
9 | GUPTA, S , MAHIPAL, A , (2013) ROLE OF SYSTEMIC CHEMOTHERAPY IN UROTHELIAL URINARY BLADDER CANCER.CANCER CONTROL. VOL. 20. ISSUE 3. P. 200 -210 | 70 | 88% | 11 |
10 | PLIARCHOPOULOU, K , LASCHOS, K , PECTASIDES, D , (2013) CURRENT CHEMOTHERAPEUTIC OPTIONS FOR THE TREATMENT OF ADVANCED BLADDER CANCER: A REVIEW.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. VOL. 31. ISSUE 3. P. 294-302 | 69 | 90% | 7 |
Classes with closest relation at Level 1 |